Atect Corp operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Atect Corp with three other
pharmaceutical manufacturers in Asia:
sales of 63.67 billion Indian Rupees [US$853.20 million]
of which 33%
was Small Molecules),
Panacea Biotec Ltd
(5.44 billion Indian Rupees [US$72.90 million]
Hester Pharmaceuticals Limited
based in INDIA
(1.83 billion Indian Rupees [US$24.56 million]
of which 66%
was Poultry Vaccines).
Atect Corp reported sales of ¥2.98 billion (US$27.96 million)
March of 2020.
a very small
increase of 0.7%
versus 2019, when the company's sales were ¥2.96 billion.
Sales at Atect Corp have increased during each of the previous five years
(and since 2015, sales have increased a total of 26%).